Le Lézard
Classified in: Health
Subject: SVY

Sequencing Of Stevia Plant Genome Revealed For The First Time By PureCircle Stevia Institute At The International Congress Of Nutrition


BUENOS AIRES, Argentina, Oct. 19, 2017 /CNW/ -- For the first time, scientists have completed the sequencing of the stevia plant genome. Lead scientists from PureCircle Stevia Institute and KeyGene have unveiled this major breakthrough in research showing the annotated, high-quality genome sequences of three stevia cultivars.

This achievement provides a better understanding of key enzyme groups used by the stevia plant to produce the steviol glycosides giving stevia its characteristic sweet taste. To enable acceleration of the traditional breeding of the stevia plant, researchers identified several million potentially new markers in the assembled genomes.

PureCircle's non-GMO agriculture program is strengthened by these cutting-edge findings. The research helps facilitate optimization of the levels of the best-tasting steviol glycosides, including improvements in the levels of the well-known minor glycosides, Reb D and Reb M.

The data has been integrated into CropPedia, a comprehensive bioinformatics platform developed by KeyGene for visualization and analytics of all available genomic, transcriptomic and metabolomic stevia datasets. CropPedia enables chemists, biochemists, geneticists and agronomists to better understand the steviol glycoside biosynthesis pathways, and to rapidly create improved stevia varieties using traditional breeding practices.

Stevia is a plant-based, zero-calorie sweetener which has been approved by all major regulatory authorities globally for use in foods and beverages in over 150 countries.

Optimized stevia ingredients developed as a result of this research will enable deeper reductions in sugar and calorie content of foods and beverages, as well as superior tasting products. This greatly benefits consumers around the world by helping them meet dietary guidelines calling for reductions in sugar and calorie intake for improved health.

"PureCircle is committed to strengthening the understanding of the stevia leaf," said Avetik Markosyan, Vice President, Head of Group Research and Development at PureCircle. "These findings provide strategic enhancements to our breeding and agronomy programs, as well as tremendous utility for scientists, farmers and developers working with stevia as a non-GMO ingredient."

"Having a single high-quality reference genome is generally considered a major step forward for newly domesticated crops, such as stevia," said Arjen van Tunen, CEO of KeyGene. "We have surpassed this benchmark with three independent reference genomes for stevia. This comprehensive understanding of the complexities of the stevia genome will directly translate to high?value, improved stevia varieties."

"Being an industry leader, agronomic research is an investment PureCircle values highly," said Faith Son, Vice President, Head of Marketing and Innovation at PureCircle. "This is indeed the stevia leaf's next step towards creating a clearer path to great taste and understanding all of the immense benefits the plant contains for the global food and beverage industry, as well as consumers."

PureCircle Ltd. and The Coca-Cola Company co-funded this research.

 

SOURCE PureCircle Stevia Institute


These press releases may also interest you

at 03:00
ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of microRNAs, today announced an oral presentation at the upcoming Oligonucleotide & Peptide Therapeutics (TIDES) Conference...

at 02:32
With every successive year, the lines between medical devices and consumer electronics become increasingly blurred ? medtech companies seek to expand their reach beyond patients, and consumer electronics companies have targeted medical applications...

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...



News published on and distributed by: